RecruitingNCT06819969

The Canadian Lung Outcomes in Users of Vaping Devices Study

The Canadian Lung Outcomes in Users of Vaping Devices (CLOUD) Study


Sponsor

University of British Columbia

Enrollment

500 participants

Start Date

Jul 25, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Vaping is increasingly popular with both adolescent and adult Canadians, but the long-term health impacts remain unknown. We believe that the tools we currently have to detect lung disease in people who vape may be insufficient and propose new ways to find lung injuries that may impact them over the course of their lives. These include exercise testing, new imaging techniques, and new breathing tests that will demonstrate how vaping may harm their lungs. We will use these tools in both adolescent and adult Canadians to give Canadians who vape important information on the consequences of vaping.


Eligibility

Min Age: 12 Years

Inclusion Criteria6

  • Adolescent arm:
  • Aged ≥12 and \<19 years old
  • Either 1) use neither combustible cigarettes nor e-cigarettes or 2) use e-cigarettes exclusively
  • Adult arm:
  • Aged ≥19 years old
  • Fall into one of the following categories: 1) use neither combustible cigarettes nor e-cigarettes; 2) use combustible cigarettes exclusively, never using e-cigarettes; 3) use e-cigarettes exclusively, never using combustible cigarettes; or 4) use both combustible cigarettes and e-cigarettes currently

Exclusion Criteria12

  • Adolescent arm:
  • Contraindication to pulmonary function testing and cardiopulmonary exercise testing
  • Have smoked combustible cannabis within the last month and/or have a combustible cannabis smoking history of \>1 joint-year
  • Have smoked combustible cigarettes within the last 6 months
  • Have a physician-diagnosed chronic lung disease (such as asthma, cystic fibrosis, or bronchopulmonary dysplasia)
  • Inability to provide written informed consent
  • Adult arm:
  • Contraindication to pulmonary function testing and cardiopulmonary exercise testing
  • Have smoked combustible cannabis within the last month and/or have a combustible cannabis smoking history of \>1 joint-year
  • Currently undergoing treatment for lung cancer
  • Inability to provide written informed consent
  • No limitations will be placed on the type of e-liquids used by participants; e.g., e-cigarette users of nicotine, tetrahydrocannabinol, and cannabidiol will be all enrolled.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(8)

University of Alberta (Clinical Sciences Building)

Edmonton, Alberta, Canada

BC Cancer Agency

Vancouver, British Columbia, Canada

BC Children's Hospital Research Institute

Vancouver, British Columbia, Canada

St. Paul's Hospital

Vancouver, British Columbia, Canada

McMaster University (Research Institute of St. Joe's Hamilton)

Hamilton, Ontario, Canada

University of Ottawa (The Ottawa Hospital General Campus)

Ottawa, Ontario, Canada

University of Toronto (The Hospital for Sick Children)

Toronto, Ontario, Canada

Université de Sherbrooke

Sherbrooke, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06819969


Related Trials